ArticleCancer chemotherapy and pharmacology2022

A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors.

C Massard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.